Cindy Lea Bell

Executive Vice President-Corporate Development at Genome Canada

Cindy Lea Bell

Cindy Lea Bell

Executive Vice President-Corporate Development at Genome Canada

Biography

Dr. Cindy L. Bell is an Executive Vice President-Corporate Development at Genome Canada. She is on the Board of Directors at Structural Genomics Consortium. She received her doctorate degree from McGill University.

Overview
RelSci Relationships

9

Number of Boards

1

Relationships
RelSci Relationships are individuals Cindy Lea Bell likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at BioContact (Québec), Inc.

Relationship likelihood: Strong

Director-Communications & Events at Genome Canada

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Genome Canada

Relationship likelihood: Strong

Vice President-Genomics Program at Genome Canada

Relationship likelihood: Strong

Former Chief Executive Officer at Clinical Research Development Ireland

Relationship likelihood: Average

Former Chief Financial Officer at VBI Vaccines, Inc.

Relationship likelihood: Average

Former Executive Vice President at Medical Discovery Management Corp.

Relationship likelihood: Weak

President at Pacific Biopharma Associates

Relationship likelihood: Weak

Chief Executive Officer at Prognomix, Inc.

Relationship likelihood: Weak

Paths to Cindy Lea Bell
Potential Connections via
Relationship Science
You
Cindy Lea Bell
Executive Vice President-Corporate Development at Genome Canada
Education
Class of 1986

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Career History
Executive Vice President-Corporate Development
2000 - Current

Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada.

Boards & Committees
Director
Current

Structural Genomics Consortium is a British private company located in Headington that operates as a non-profit organization that determines three-dimensional structures of proteins of medical relevance. The firm was founded by Pär Nordlund.The company says this about itself: The SGC is a pre-competitive public-private partnership that accelerates research in human biology and drug discovery by making all of its research output freely available to the scientific community. To achieve its mission, the organization is building an open and collaborative network of scientists. The SGC has active research facilities at seven leading academic institutions across the globe (Toronto and Montreal-Canada, Oxford-UK, UNICAMP-Brazil, Karolinska-Sweden, UNC Chapel Hill-USA and Frankfurt-Germany), and SGC scientists collaborate with more than 300 researchers in academia and industry.

Other Affiliations

Cindy Lea Bell is affiliated with Genome Canada, Structural Genomics Consortium

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cindy Lea Bell. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cindy Lea Bell's profile does not indicate a business or promotional relationship of any kind between RelSci and Cindy Lea Bell.